Search Results - "Parent, Pauline"

A comprehensive overview of promising biomarkers in stage II colorectal cancer by Parent, Pauline, Cohen, Romain, Rassy, Elie, Svrcek, Magali, Taieb, Julien, André, Thierry, Turpin, Anthony

“…•Adjuvant chemotherapy in stage II CC patients is guided by clinicopathologic findings.•Novel biomarkers to lead to more accurate treatment decisions are an…”
Get full text

Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer by Parent, Pauline, Marcq, Gautier, Adeleke, Sola, Turpin, Anthony, Boussios, Stergios, Rassy, Elie, Penel, Nicolas

“…Immune checkpoint inhibitors (ICIs) are commonly used to treat patients with advanced urothelial cancer. However, a significant number of patients do not…”
Get full text

Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study by Epaillard, Nicolas, Parent, Pauline, Loriot, Yohann, Lavaud, Pernelle, Vera-Cea, E-B, Martinez-Chanza, Nieves, Rodriguez-Vida, Alejo, Dumont, Clement, Lozano, Rebeca, Llácer, Casilda, Ratta, Raffaele, Oudard, Stephane, Thibault, Constance, Auclin, Edouard

“…Less than one-third of bladder cancers are non-pure urothelial carcinoma [with variant histological (VH) or non-urothelial carcinoma (non-UC)] for which no…”
Get full text

New rising entities in cancer of unknown primary: Is there a real therapeutic benefit? by Rassy, Elie, Parent, Pauline, Lefort, Felix, Boussios, Stergios, Baciarello, Giulia, Pavlidis, Nicholas

“…•CUP accounts for approximately 1–3 % of all malignant neoplasms.•CUP patients are categorized according to their clinicopathological characteristics.•Empiric…”
Get full text

BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer by Ambrosini, Margherita, Tougeron, David, Modest, Dominik, Guimbaud, Rosine, Kopetz, Scott, Decraecker, Marie, Kim, Stefano, Coutzac, Clelia, Perkins, Geraldine, Alouani, Emily, Marmorino, Federica, Pernot, Simon, Sinicrope, Frank A, Elez, Elena, Parent, Pauline, Cremolini, Chiara, Pietrantonio, Filippo, Lonardi, Sara, Gallois, Claire, Taieb, Julien

“…Immune checkpoint inhibitors (ICIs) are the guideline endorsed first choice for patients with deficient mismatch repair or microsatellite instability high…”
Get full text

Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in non-small-cell lung cancer (NSCLC) with c-METexon 14 skipping mutations ( MET ex14) by Brandao, Mariana da Rocha Almeida, Zugazagoitia, Jon, Dingemans, Anne-Marie C., Duruisseaux, Michaël, Parent, Pauline, Juan-Vidal, Oscar, Spira, Alexander I., Vicier, Cecile, Zalcman, Gerard, Barasa, Ben, Yan, Chris, Doze, Petra, Joe, Andrew K., Laus, Gianluca, Felip, Enriqueta

“…8583 Background: Epidermal growth factor receptor (EGFR) and hepatocyte growth factor receptor (c-MET) are dysregulated in many tumors, including NSCLC. In…”
Get full text

Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor by Turpin, Anthony, Delliaux, Carine, Parent, Pauline, Chevalier, Hortense, Escudero-Iriarte, Carmen, Bonardi, Franck, Vanpouille, Nathalie, Flourens, Anne, Querol, Jessica, Carnot, Aurélien, Leroy, Xavier, Herranz, Nicolás, Lanel, Tristan, Villers, Arnauld, Olivier, Jonathan, Touzet, Hélène, de Launoit, Yvan, Tian, Tian V., Duterque-Coquillaud, Martine

“…Background Neuroendocrine prostate cancer (NEPC) is an aggressive form of prostate cancer, arising from resistance to androgen-deprivation therapies. However,…”
Get full text

Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor by Turpin, Anthony, Delliaux, Carine, Parent, Pauline, Chevalier, Hortense, Escudero-Iriarte, Carmen, Bonardi, Franck, Vanpouille, Nathalie, Flourens, Anne, Querol, Jessica, Carnot, Aurélien, Leroy, Xavier, Herranz, Nicolás, Lanel, Tristan, Villers, Arnauld, Olivier, Jonathan, Touzet, Hélène, de Launoit, Yvan, Tian, Tian V, Duterque-Coquillaud, Martine

“…Background: Neuroendocrine prostate cancer (NEPC) is an aggressive form of prostate cancer, arising from resistance to androgen-deprivation therapies. However,…”
Get full text

Association of the Lung Immune Prognostic Index with outcome in patients with metastatic urothelial cancer treated with immune checkpoint inhibitor by Pauline, Parent, Auclin, Edouard, Mezquita, Laura, Chanza, Nieves M., Dumont, Clement, Rodriguez-Vida, Alejo, Lozano, Rebeca, Vera, Beatriz, Ratta, Raffaele, Baciarello, Giulia, Colomba, Emeline, Fuerea, Alina, Besse, Benjamin, Loriot, Yohann, Lavaud, Pernelle

“…Abstract only 545 Background: Prognostic factors for survival in metastatic urothelial carcinoma (mUC) have been reported in patients (pts) treated with…”
Get full text

Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma by Parent, Pauline, Auclin, Edouard, Patrikidou, Anna, Mezquita, Laura, Martínez Chanzá, Nieves, Dumont, Clément, Rodriguez-Vida, Alejo, Llacer, Casilda, Lozano, Rebeca, Ratta, Raffaele, Merseburger, Axel S, Sternberg, Cora N, Baciarello, Giulia, Colomba, Emeline, Fuerea, Alina, Besse, Benjamin, Loriot, Yohann, Lavaud, Pernelle

“…Few prognostic factors have been identified in patients with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs). The Lung…”
Get full text

Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors by Mokbel, Sara, Baciarello, Giuilia, Lavaud, Pernelle, Omlin, Aurelius, Calabrò, Fabio, Cathomas, Richard, Aeppli, Stefanie, Parent, Pauline, Giannatempo, Patrizia, Koster, Kira-Lee, Appel, Naara, Gonnet, Philippe, Angius, Gesuino, Tsantoulis, Petros, Arkenau, Hendrick-Tobias, Cattrini, Carlo, Messina, Carlo, Zeghondy, Jean, Morelli, Cristina, Loriot, Yohann, Formica, Vincenzo, Patrikidou, Anna

“…Immune checkpoint inhibitors (ICIs) improve overall survival (OS) in advanced/metastatic urothelial cancer (a/mUC) patients. Preliminary evidence suggests a…”
Get full text

Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2 by Turpin, Anthony, Delliaux, Carine, Parent, Pauline, Chevalier, Hortense, Escudero-Iriarte, Carmen, Bonardi, Franck, Vanpouille, Nathalie, Flourens, Anne, Querol, Jessica, Carnot, Aurélien, Leroy, Xavier, Herranz, Nicolás, Lanel, Tristan, Villers, Arnauld, Olivier, Jonathan, Touzet, Hélène, de Launoit, Yvan, Tian, Tian, Duterque-Coquillaud, Martine

“…Prostate cancer (PCa) is one of the major public health problems in Western countries. Recently, the TMPRSS2:ERG gene fusion, which results in the aberrant…”
Get full text

An investigation of concentrated and distributed strain inducing constraints for training shape memory alloys by Parent, Pauline Marie

“…Borderline personality disorder (BPD) is a severe mental illness characterized by high rates of engagement in distress-induced risk behavior. Unfortunately,…”
Get full text

An investigation of concentrated and distributed strain inducing constraints for training shape memory alloys by Parent, Pauline Marie

“…Borderline personality disorder (BPD) is a severe mental illness characterized by high rates of engagement in distress-induced risk behavior. Unfortunately,…”
Get full text